The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications
International Journal of Molecular Sciences · 02.03.2023 · 24 (5) · 4841
DOI: 10.3390/ijms24054841 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.03.2023. Verfasst von Ulrich Wirth und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, 81377 Munich, Germany. Hauptthemen laut MEDLINE: Liver Transplantation, Microbiota, Biliary Tract, Gastrointestinal Microbiome. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung, Else Kröner-Fresenius Stiftung.
Abstract (Originalsprache)
Liver transplantation as a treatment option for end-stage liver diseases is associated with a relevant risk for complications. On the one hand, immunological factors and associated chronic graft rejection are major causes of morbidity and carry an increased risk of mortality due to liver graft failure. On the other hand, infectious complications have a major impact on patient outcomes. In addition, abdominal or pulmonary infections, and biliary complications, including cholangitis, are common complications in patients after liver transplantation and can also be associated with a risk for mortality. Thereby, these patients already suffer from gut dysbiosis at the time of liver transplantation due to their severe underlying disease, causing end-stage liver failure. Despite an impaired gut-liver axis, repeated antibiotic therapies can cause major changes in the gut microbiome. Due to repeated biliary interventions, the biliary tract is often colonized by several bacteria with a high risk for multi-drug resistant germs causing local and systemic infections before and after liver transplantation. Growing evidence about the role of gut microbiota in the perioperative course and their impact on patient outcomes in liver transplantation is available. However, data about biliary microbiota and their impact on infectious and biliary complications are still sparse. In this comprehensive review, we compile the current evidence for the role of microbiome research in liver transplantation with a focus on biliary complications and infections due to multi-drug resistant germs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, 81377 Munich, Germany.
- Department of Medicine II, University Hospital, Ludwig-Maximilians-University Munich, 81377 Munich, Germany.
ORCID-Profile: Ulrich Wirth, Tianxiao Jiang, Josefine Schardey, Malte Schirren, Joachim Andrassy
Förderung
- Else Kröner-Fresenius-Stiftung
- Else Kröner-Fresenius Stiftung
Zitieren
APA
Wirth, U., Jiang, T., Schardey, J., Kratz, K., Li, M., Schirren, M., Kühn, F., Bazhin, A., Werner, J., Guba, M., Schulz, C., & Andrassy, J. (2023). The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications. International Journal of Molecular Sciences, 24(5), 4841. https://doi.org/10.3390/ijms24054841
Vancouver
Wirth U, Jiang T, Schardey J, Kratz K, Li M, Schirren M, et al. The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications. International Journal of Molecular Sciences. 2023;24(5):4841. doi:10.3390/ijms24054841
BibTeX
@article{Wirth2023,
author = {Wirth, Ulrich and Jiang, Tianxiao and Schardey, Josefine and Kratz, Katharina and Li, Mingming and Schirren, Malte and Kühn, Florian and Bazhin, Alexandr and Werner, Jens and Guba, Markus and Schulz, Christian and Andrassy, Joachim},
title = {The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {5},
pages = {4841},
doi = {10.3390/ijms24054841}
}
EUVIMED